MOLINA HEALTHCARE, INC.·4

Apr 2, 4:47 PM ET

ORLANDO STEVEN J 4

4 · MOLINA HEALTHCARE, INC. · Filed Apr 2, 2026

Research Summary

AI-generated summary of this filing

Updated

Molina Healthcare (MOH) Director Steven J. Orlando Receives Award

What Happened Steven J. Orlando, a director of Molina Healthcare, received an equity award of 405 shares on April 1, 2026. The shares were granted under the company’s 2025 Equity Incentive Plan at the closing price of $135.82, for an aggregate value of $55,007. This was a routine director compensation grant (award), not a market purchase or sale.

Key Details

  • Transaction type: Award/Grant (code A) of 405 shares.
  • Date and price: April 1, 2026; closing price $135.82 (resulting value $55,007).
  • Reason: Quarterly portion (one quarter) of the annual director equity award (annual target $220,000; $55,000 granted each quarter based on share price).
  • Shares held post-transaction: Shares are held by the Orlando Family Trust (filing does not state total shares owned after this grant).
  • Footnotes: F1–F4 explain the grant under the 2025 Equity Incentive Plan, the $220,000 annual director award split quarterly, the closing price used, and trust ownership.
  • Timeliness: Filed April 2, 2026 for a transaction on April 1, 2026 (appears timely).

Context This is a standard equity compensation grant to a non-employee director as part of routine board pay. Such awards are common for directors and do not, by themselves, indicate a buy or sell sentiment in the market.

Insider Transaction Report

Form 4
Period: 2026-04-01
Transactions
  • Award

    Common Stock

    [F1][F2][F3][F4]
    2026-04-01$135.82/sh+405$55,00717,730 total(indirect: By Trust)
Holdings
  • Common Stock

    (indirect: By 401(k))
    1,500
Footnotes (4)
  • [F1]Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.
  • [F2]The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on April 1, 2026 was $135.82, which resulted in a grant of 405 shares.
  • [F3]Represents the closing price of the Issuer's common stock on April 1, 2026.
  • [F4]Shares are held by Orlando Family Trust.
Signature
Jeff. D. Barlow, by power of attorney for Steven J. Orlando.|2026-04-02

Documents

2 files